| Dr Timothy Irving Messer, OD | |
|
3601 S 6th Ave, (3-124), Tucson, AZ 85723-0001 | |
| (520) 792-1450 | |
| (520) 629-4642 |
| Full Name | Dr Timothy Irving Messer |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 3601 S 6th Ave, Tucson, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043323363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1259 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy Irving Messer, OD 8246 E Galinda Dr, Tucson, AZ 85750-2421 Ph: (520) 751-7616 | Dr Timothy Irving Messer, OD 3601 S 6th Ave, (3-124), Tucson, AZ 85723-0001 Ph: (520) 792-1450 |
News Archive
Medical researchers who crave a means of exploring the genetic culprits behind a host of neuromuscular disorders may have just had their wish granted by a team working at the National Institute of Standards and Technology, where scientists have performed surgery on single cells to extract and examine their mitochondria.
In a bid to reduce the smoking rates in Australia's indigenous population the Federal Government is launching the first anti-smoking campaign this Monday (today) aimed specifically at indigenous Australians. Figures have shown that nearly 50% Aboriginal and Torres Strait Islander people smoke, and one in five die from smoking-related diseases. According to Government spokesmen the new campaign is part of its plan to halve the number of indigenous smokers by 2018. The radio, television and print campaign will cost $4 million and is part of the Government's wider aim to significantly reduce the number of Australians who smoke.
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to develop. The compound has been shown to be effective in treating mice with breast and prostate cancer and is now rapidly progressing towards the first clinical trials in patients.
A new educational program aims to help health professionals keep up to date with the latest evidence on second and third line medicines for lowering blood glucose.
› Verified 8 days ago
Adam Mcdonald, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 525 W Wetmore Rd, Tucson, AZ 85705 Phone: 520-293-2363 | |
Dr. Tami Cordt Friske, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5720 E Broadway Blvd, Tucson, AZ 85711 Phone: 520-747-8583 Fax: 520-747-8561 | |
Robert Iverson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4631 N Oracle Rd, #175, Tucson, AZ 85705 Phone: 520-408-1200 Fax: 520-408-2552 | |
Dr. David Louis Nanni, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6255 E Grant Rd, Tucson, AZ 85712 Phone: 520-885-0582 Fax: 520-886-6538 | |
Dr. Paul Cinalli, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 440 N Alvernon Way, Tucson, AZ 85711 Phone: 520-327-6215 Fax: 520-327-0368 | |
Phu Minh Huynh Lam, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1225 W Irvington Rd, Target Optical, Tucson, AZ 85714 Phone: 520-295-3669 Fax: 520-295-3703 | |
Gabriel Zelaya, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6615 N Oracle Rd, Tucson, AZ 85704 Phone: 520-797-8000 |